These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12208340)
1. Combined shock-wave and immunogene therapy of mouse melanoma and renal carcinoma tumors. Song J; Tata D; Li L; Taylor J; Bao S; Miller DL Ultrasound Med Biol; 2002 Jul; 28(7):957-64. PubMed ID: 12208340 [TBL] [Abstract][Full Text] [Related]
2. Lithotripter shock waves with cavitation nucleation agents produce tumor growth reduction and gene transfer in vivo. Miller DL; Song J Ultrasound Med Biol; 2002 Oct; 28(10):1343-8. PubMed ID: 12467861 [TBL] [Abstract][Full Text] [Related]
3. In vivo transfection of melanoma cells by lithotripter shock waves. Bao S; Thrall BD; Gies RA; Miller DL Cancer Res; 1998 Jan; 58(2):219-21. PubMed ID: 9443395 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2. Kudo-Saito C; Wansley EK; Gruys ME; Wiltrout R; Schlom J; Hodge JW Clin Cancer Res; 2007 Mar; 13(6):1936-46. PubMed ID: 17363550 [TBL] [Abstract][Full Text] [Related]
5. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558 [TBL] [Abstract][Full Text] [Related]
6. Direct transfer of IL-12 gene into growing Renca tumors. Budryk M; WilczyĆska U; Szary J; Szala S Acta Biochim Pol; 2000; 47(2):385-91. PubMed ID: 11051203 [TBL] [Abstract][Full Text] [Related]
7. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells. Nishitani MA; Sakai T; Ishii K; Zhang M; Nakano Y; Nitta Y; Miyazaki J; Kanayama HO; Kagawa S; Himeno K Cancer Gene Ther; 2002 Feb; 9(2):156-63. PubMed ID: 11857033 [TBL] [Abstract][Full Text] [Related]
8. The in vitro and in vivo effects of extracorporeal shock waves on malignant cells. Randazzo RF; Chaussy CG; Fuchs GJ; Bhuta SM; Lovrekovich H; deKernion JB Urol Res; 1988; 16(6):419-26. PubMed ID: 3232275 [TBL] [Abstract][Full Text] [Related]
10. Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Miller DL; Song J Ultrasound Med Biol; 2003 Jun; 29(6):887-93. PubMed ID: 12837504 [TBL] [Abstract][Full Text] [Related]
11. Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells. Weiss JM; Shivakumar R; Feller S; Li LH; Hanson A; Fogler WE; Fratantoni JC; Liu LN Cancer Gene Ther; 2004 May; 11(5):346-53. PubMed ID: 15031722 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration. Hara I; Nagai H; Miyake H; Yamanaka K; Hara S; Micallef MJ; Kurimoto M; Gohji K; Arakawa S; Ichihashi M; Kamidono S Cancer Gene Ther; 2000 Jan; 7(1):83-90. PubMed ID: 10678360 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity. Saffran DC; Horton HM; Yankauckas MA; Anderson D; Barnhart KM; Abai AM; Hobart P; Manthorpe M; Norman JA; Parker SE Cancer Gene Ther; 1998; 5(5):321-30. PubMed ID: 9824052 [TBL] [Abstract][Full Text] [Related]
14. Ultrasonic enhancement of gene transfection in murine melanoma tumors. Miller DL; Bao S; Gies RA; Thrall BD Ultrasound Med Biol; 1999 Nov; 25(9):1425-30. PubMed ID: 10626630 [TBL] [Abstract][Full Text] [Related]
15. Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma. Huang P; Kaku H; Chen J; Kashiwakura Y; Saika T; Nasu Y; Urata Y; Fujiwara T; Watanabe M; Kumon H Cancer Gene Ther; 2010 Jul; 17(7):484-91. PubMed ID: 20168351 [TBL] [Abstract][Full Text] [Related]
16. The dual effect of ultrasound-targeted microbubble destruction in mediating recombinant adeno-associated virus delivery in renal cell carcinoma: transfection enhancement and tumor inhibition. Li F; Jin L; Wang H; Wei F; Bai M; Shi Q; Du L J Gene Med; 2014; 16(1-2):28-39. PubMed ID: 24464622 [TBL] [Abstract][Full Text] [Related]
17. Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects. Budd GT; Osgood B; Barna B; Boyett JM; Finke J; Medendorp SV; Murthy S; Novak C; Sergi J; Tubbs R Cancer Res; 1989 Nov; 49(22):6432-6. PubMed ID: 2804986 [TBL] [Abstract][Full Text] [Related]
18. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity. Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876 [TBL] [Abstract][Full Text] [Related]
19. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model. Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145 [TBL] [Abstract][Full Text] [Related]
20. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Sun WH; Burkholder JK; Sun J; Culp J; Turner J; Lu XG; Pugh TD; Ershler WB; Yang NS Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2889-93. PubMed ID: 7708743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]